APA (7th ed.) Citation

Goldschmidt, H., Mai, E. K., Hose, D., Jauch, A., Hillengaß, J., Raab, M., . . . Hielscher, T. (2018). Bortezomib before and after high-dose therapy in myeloma: Long-term results from the phase III HOVON-65/GMMG-HD4 trial. Leukemia, 32, . https://doi.org/10.1038/leu.2017.211

Chicago Style (17th ed.) Citation

Goldschmidt, Hartmut, Elias K. Mai, Dirk Hose, Anna Jauch, Jens Hillengaß, Marc-Steffen Raab, Uta Bertsch, and Thomas Hielscher. "Bortezomib Before and After High-dose Therapy in Myeloma: Long-term Results from the Phase III HOVON-65/GMMG-HD4 Trial." Leukemia 32 (2018). https://doi.org/10.1038/leu.2017.211.

MLA (9th ed.) Citation

Goldschmidt, Hartmut, et al. "Bortezomib Before and After High-dose Therapy in Myeloma: Long-term Results from the Phase III HOVON-65/GMMG-HD4 Trial." Leukemia, vol. 32, 2018, https://doi.org/10.1038/leu.2017.211.